Genmab | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Almirall EUR 1.46B 37.19M 2025-06
Amarin USD 473.69M 12.49M 2025-03
Amgen USD 6.21B 330M 2025-03
argenx SE 6.1B 597.47M 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Bayer EUR 32.58B 537M 2025-03
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Demant DKK 9.56B 42M 2024-12
Exelixis USD 2.03B 97.49M 2025-07
Fresenius Medical Care EUR 15.5B 928.44M 2025-03
Galapagos EUR 2.64B 104.07M 2025-06
Genmab DKK 5.3B 31.4B 2025-03
GlaxoSmithKline GBP 14.35B 197M 2025-06
GN Store Nord DKK 10.75B 72M 2025-03
GRIFOLS EUR 7.6B 1.96B 2025-06
Hikma Pharmaceutical USD 2.32B 35M 2024-12
Insmed USD 1.25B 1.15B 2025-06
Lonza CHF 9.33B 23M 2024-12
Merck EUR 28.26B 1.64B 2025-06
Novartis USD 42.05B 3.6B 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
UCB EUR 10.03B 1.08B 2024-12


Genmab Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.